Agencies | Governor
Virginia Regulatory Town Hall
Virginia Racing Commission
Virginia Racing Commission
Medication [11 VAC 10 ‑ 180]
This action is exempt from the executive branch review process.
To amend Chapter 180
General Information
Action Summary The major changes to these sections include the prohibition of anabolic or androgenic steroids, or both, and other like substances, except for boldenone, stanozolol, nandrolone, and testosterone individually but not in combination (stacking or layering) and a clarification of when adjunct bleeder medications can be given on race day (no less than three hours before post time). These rule changes are consistent with the Model Rules of Racing published by the Association of Racing Commissioners International.
Chapters Affected Only affects this chapter.
Exempt from APA Yes, this action is exempt from Article II of the APA and executive branch review.
Exempt Citation: 2.2-4002 (B)(23)
RIS Project No project yet assigned to this action
New Periodic Review This action will not be used to conduct a new periodic review.
Stages associated with this regulatory action.
Stage ID Stage Type Status
4146 Final Stage complete. This regulation became effective on 05/18/2007.
Contact Information
Name / Title: Kimberly Mackey  / Regulatory Coordinator
Address: 5707 Huntsman Road
Suite 201-B
Richmond, VA 23250
Email Address:
Phone: (804)966-7406    FAX: ()-    TDD: ()-

This person is the primary contact for this board.